Bluejay Diagnostics (BJDX) Competitors $3.81 -0.03 (-0.78%) Closing price 03/28/2025 03:59 PM EasternExtended Trading$3.52 -0.29 (-7.48%) As of 03/28/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BJDX vs. STRR, BSGM, MHUA, LUCY, POAI, OSRH, BLAC, PSTV, AEMD, and CHEKShould you be buying Bluejay Diagnostics stock or one of its competitors? The main competitors of Bluejay Diagnostics include Star Equity (STRR), BioSig Technologies (BSGM), Meihua International Medical Technologies (MHUA), Innovative Eyewear (LUCY), Predictive Oncology (POAI), OSR (OSRH), Bellevue Life Sciences Acquisition (BLAC), Plus Therapeutics (PSTV), Aethlon Medical (AEMD), and Check-Cap (CHEK). These companies are all part of the "medical equipment" industry. Bluejay Diagnostics vs. Star Equity BioSig Technologies Meihua International Medical Technologies Innovative Eyewear Predictive Oncology OSR Bellevue Life Sciences Acquisition Plus Therapeutics Aethlon Medical Check-Cap Star Equity (NASDAQ:STRR) and Bluejay Diagnostics (NASDAQ:BJDX) are both small-cap multi-sector conglomerates companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, earnings, institutional ownership, community ranking and profitability. Which has stronger earnings and valuation, STRR or BJDX? Star Equity has higher revenue and earnings than Bluejay Diagnostics. Star Equity is trading at a lower price-to-earnings ratio than Bluejay Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioStar Equity$53.36M0.15$25.13M-$3.91-0.64Bluejay Diagnostics$250K8.43-$9.95M-$1.37 thousand0.00 Is STRR or BJDX more profitable? Bluejay Diagnostics has a net margin of 0.00% compared to Star Equity's net margin of -12.41%. Star Equity's return on equity of -8.72% beat Bluejay Diagnostics' return on equity.Company Net Margins Return on Equity Return on Assets Star Equity-12.41% -8.72% -4.62% Bluejay Diagnostics N/A -155.67%-117.82% Do institutionals and insiders have more ownership in STRR or BJDX? 3.8% of Star Equity shares are owned by institutional investors. Comparatively, 18.5% of Bluejay Diagnostics shares are owned by institutional investors. 33.5% of Star Equity shares are owned by company insiders. Comparatively, 0.4% of Bluejay Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, STRR or BJDX? Star Equity has a beta of 0.07, suggesting that its stock price is 93% less volatile than the S&P 500. Comparatively, Bluejay Diagnostics has a beta of 0.38, suggesting that its stock price is 62% less volatile than the S&P 500. Does the media refer more to STRR or BJDX? In the previous week, Star Equity had 8 more articles in the media than Bluejay Diagnostics. MarketBeat recorded 10 mentions for Star Equity and 2 mentions for Bluejay Diagnostics. Bluejay Diagnostics' average media sentiment score of 1.43 beat Star Equity's score of 0.11 indicating that Bluejay Diagnostics is being referred to more favorably in the news media. Company Overall Sentiment Star Equity Neutral Bluejay Diagnostics Positive Does the MarketBeat Community prefer STRR or BJDX? Star Equity received 1 more outperform votes than Bluejay Diagnostics when rated by MarketBeat users. Likewise, 100.00% of users gave Star Equity an outperform vote while only 66.67% of users gave Bluejay Diagnostics an outperform vote. CompanyUnderperformOutperformStar EquityOutperform Votes3100.00% Underperform VotesNo VotesBluejay DiagnosticsOutperform Votes266.67% Underperform Votes133.33% SummaryStar Equity beats Bluejay Diagnostics on 9 of the 15 factors compared between the two stocks. Remove Ads Get Bluejay Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for BJDX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BJDX vs. The Competition Export to ExcelMetricBluejay DiagnosticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.11M$4.35B$5.63B$7.84BDividend YieldN/A48.03%5.33%4.01%P/E Ratio0.0028.4223.5818.74Price / Sales8.4349.24388.2390.77Price / CashN/A51.0838.1734.64Price / Book0.006.116.894.23Net Income-$9.95M$67.64M$3.20B$247.47M7 Day Performance-9.07%-5.25%-3.06%-2.29%1 Month Performance-10.98%-4.12%1.51%-5.81%1 Year Performance-98.81%10.65%9.37%-0.96% Bluejay Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BJDXBluejay Diagnostics1.1306 of 5 stars$3.81-0.8%N/A-98.8%$2.11M$250,000.000.009Short Interest ↓Gap DownSTRRStar Equity1.1784 of 5 stars$2.67+10.3%N/A-43.2%$8.59M$50.38M-1.04460Analyst RevisionPositive NewsGap UpHigh Trading VolumeBSGMBioSig Technologies1.8134 of 5 stars$0.49-9.4%$2.75+456.9%-10.7%$8.51M$39,000.000.0050News CoverageHigh Trading VolumeMHUAMeihua International Medical Technologies2.0812 of 5 stars$0.34-1.0%N/A-53.9%$8.49M$94.25M0.00620Short Interest ↓LUCYInnovative Eyewear0.9048 of 5 stars$3.18-5.6%$20.00+528.9%-49.8%$7.77M$1.56M-0.339Earnings ReportGap DownPOAIPredictive Oncology2.2493 of 5 stars$1.12+0.9%$3.00+167.9%-43.1%$7.67M$1.48M-0.3730Short Interest ↓News CoverageOSRHOSRN/A$1.73+1.2%N/AN/A$6.99M$4.89B0.00N/ANews CoveragePositive NewsBLACBellevue Life Sciences AcquisitionN/A$1.71+7.5%N/A-77.5%$6.91MN/A0.00N/APSTVPlus Therapeutics1.7303 of 5 stars$1.14-3.4%$12.00+952.6%-35.7%$6.72M$4.91M-0.4520Earnings ReportAnalyst ForecastShort Interest ↑Analyst RevisionNews CoverageGap DownHigh Trading VolumeAEMDAethlon Medical2.918 of 5 stars$0.43-0.2%$7.00+1,531.7%-78.2%$6.20M$570,000.00-0.2710Analyst ForecastShort Interest ↓News CoverageCHEKCheck-Cap1.0577 of 5 stars$0.91+3.0%N/A-74.6%$5.30MN/A-0.3080Analyst ForecastShort Interest ↓Gap Down Remove Ads Related Companies and Tools Related Companies Star Equity Alternatives BioSig Technologies Alternatives Meihua International Medical Technologies Alternatives Innovative Eyewear Alternatives Predictive Oncology Alternatives OSR Alternatives Bellevue Life Sciences Acquisition Alternatives Plus Therapeutics Alternatives Aethlon Medical Alternatives Check-Cap Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BJDX) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bluejay Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bluejay Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
